Evidence map›Paper›PMID 37027103›Full record

ArticleClinical hematology international2023

CD34 Stem Cell Boost in Pediatric Allogeneic Stem Cell Transplant Recipients: A Case Series and Review of Literature.

Sara Bowman, Joe Stanek, Rajinder Bajwa, Veronika Polishchuk, Rolla Abu-Arja, Hemalatha G Rangarajan

Open access · diamondAbstract read
In one paragraph

Article in Clinical hematology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sara BowmanDepartment of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, USA.
Joe StanekDepartment of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, USA.
Rajinder BajwaDepartment of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, USA.
Veronika PolishchukDepartment of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, USA.
Rolla Abu-ArjaDepartment of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, USA.
Hemalatha G RangarajanDepartment of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, USA. Hemalatha.rangarajan@nationwidechildrens.org.ORCID http://orcid.org/0000-0003-3371-2920
Nationwide Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with poor graft function (PGF) or declining donor chimerism (DC) post allogeneic hematopoietic cell transplantation (HCT) may benefit from a CD34-selected stem cell boost (SCB). We retrospectively studied outcomes of fourteen pediatric patients (PGF: 12 and declining DC: 2), with a median age of 12.8 (range 0.08-20.6) years at HCT, who received a SCB. Primary and secondary endpoints included resolution of PGF or improvement in DC (≥ 15% increase), overall survival (OS) and transplant-related mortality (TRM), respectively. The median CD34 dose infused was 7.47 × 10

Indexed as

CD34 stem cell boostOutcomesPediatricsPost stem cell transplant

Identifiers

PMID37027103
PMCPMC10241744
OpenAlexW4362693102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.